Journal
ADVANCED MATERIALS
Volume 35, Issue 7, Pages -Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/adma.202208817
Keywords
cascade catalysis; enzyodynamic therapy; pyroptosis; ultrasound; valence change
Ask authors/readers for more resources
This study developed an ultrasound-enhanced enzyme dynamic therapy to induce pyroptosis in breast cancer cells and achieve efficient treatment by increasing the rate of reactive oxygen species (ROS) generation. The perovskite nanocrystals used in this therapy possess multiple enzyme-like activities and can counteract apoptosis resistance through cascade reactions. Ultrasound stimulation promotes ROS production and facilitates the pyroptosis process through a specific signaling pathway. In vitro and in vivo experiments confirm the superiority of this method in anti-tumor treatment.
Overcoming apoptosis resistance to achieve efficient breast cancer treatment remains a challenge. The precise induction of another form of programmed cell death, pyroptosis, is an excellent alternative for treating cancer. Ultrasound (US)-enhanced enzyme dynamic (enzyodynamic) therapy is developed by employing LaFeO3 (LFO) perovskite nanocrystals as a substrate to increase the rate of deleterious reactive oxygen species (ROS) generation for intensive cell pyroptosis. LFO nanocrystals possess quadruple enzyme-mimicking activities, including oxidase-, peroxidase-, glutathione peroxidase-, and catalase-mimicking activities, which undertake the dominant therapeutic task through cascade catalytic reactions, including the reversal of hypoxic microenvironment, depletion of endogenous glutathione, and continuous output of ROS. US exogenous stimulation increases the transition rate of the intermediate complex to Fe (II) and favors incremental ROS production, by which the ROS burst-induced pyroptosis process is accomplished through the ROS-TXNIP-NLRP3-GSDMD pathway. Both in vitro and in vivo antineoplastic outcomes affirm the ascendancy of LFO nanozyme-induced pyroptosis. This work highlights the critical role of US coupled with nanocatalytic reactors in pyroptosis-dominant breast cancer treatment with the apoptosis resistance circumvention feature.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available